TrialTranslational neurodegeneration2023

A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.

Kelsie M LaBarbera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.